A major advance in cancer investigation is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in various forms of malignancies, resulting https://bookmarkusers.com/story21741076/vhh-fragments-revive-tumor-suppressor-p53-a-potential-approach-for-cancer-therapy